Company intelligence / Profile preview

Jiangsu Run'an Pharmaceutical

Huai'an, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

Jiangsu Run'an Pharmaceutical primarily manufactures and exports APIs for established small molecule drugs addressing oncology, autoimmune, respiratory, metabolic, and other diseases. Its API and anti-tumor API workshops are FDA and international GMP compliant, and most products are supplied to regulated markets. The company is not known for novel clinical development but rather for supply of high-quality APIs to the global pharmaceutical industry[1][3][5].

Therapeutic areas: ImmunologyCardiovascularEndocrinologyPulmonologyDermatologyOncology
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Jiangsu Run'an Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiangsu Run'an Pharmaceutical.

Explore the full profile